Cartesian Therapeutics, Inc. (RNAC)
(Delayed Data from NSDQ)
$22.64 USD
+0.57 (2.58%)
Updated May 1, 2024 04:00 PM ET
After-Market: $22.82 +0.18 (0.80%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.81 | 0.00% |
Earnings Summary
For their last quarter, Cartesian Therapeutics, Inc. (RNAC) reported earnings of -$2.40 per share, missing the Zacks Consensus Estimate of -$0.30 per share. This reflects a negative earnings surprise of 700.00%. Look out for RNAC's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.81 per share, reflecting a year-over-year increase of 75.45%.
Earnings History
Price & Consensus
Zacks News for RNAC
Down -30.75% in 4 Weeks, Here's Why You Should You Buy the Dip in Cartesian Therapeutics, Inc. (RNAC)
RNAC: What are Zacks experts saying now?
Zacks Private Portfolio Services